S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
An All-In-One Guide for Trading Metals (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
An All-In-One Guide for Trading Metals (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
An All-In-One Guide for Trading Metals (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
An All-In-One Guide for Trading Metals (Ad)pixel
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NASDAQ:PDEX

Pro-Dex - PDEX Stock Forecast, Price & News

$17.51
+0.31 (+1.80%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$17.11
$18.06
50-Day Range
$16.31
$19.93
52-Week Range
$12.40
$26.50
Volume
7,718 shs
Average Volume
6,784 shs
Market Capitalization
$62.69 million
P/E Ratio
16.84
Dividend Yield
N/A
Price Target
$30.00

Pro-Dex MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
71.3% Upside
$30.00 Price Target
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.22mentions of Pro-Dex in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

868th out of 1,027 stocks

Surgical & Medical Instruments Industry

86th out of 101 stocks

PDEX stock logo

About Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Stock News Headlines

Analyzing NEXGEL (NASDAQ:NXGL) and Pro-Dex (NASDAQ:PDEX)
Pro-Dex, Inc. Announces Fiscal 2023 First Quarter Results
Pro-Dex Inc
PDEX and DPSI among mid-day movers
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Company Calendar

Last Earnings
11/15/2021
Today
12/08/2022
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PDEX
Employees
117
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+71.3%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$3.86 million
Pretax Margin
10.73%

Debt

Sales & Book Value

Annual Sales
$42.04 million
Cash Flow
$1.31 per share
Book Value
$6.54 per share

Miscellaneous

Free Float
2,055,000
Market Cap
$62.69 million
Optionable
Not Optionable
Beta
0.91

Key Executives

  • Mr. Richard Lee Van Kirk Jr. (Age 61)
    CEO & Director
    Comp: $416.38k
  • Ms. Alisha K. CharltonMs. Alisha K. Charlton (Age 52)
    CFO & Corp. Sec.
    Comp: $300.22k













PDEX Stock - Frequently Asked Questions

What is Pro-Dex's stock price forecast for 2023?

0 brokers have issued 1 year price targets for Pro-Dex's stock. Their PDEX share price forecasts range from $30.00 to $30.00. On average, they anticipate the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 71.3% from the stock's current price.
View analysts price targets for PDEX
or view top-rated stocks among Wall Street analysts.

How have PDEX shares performed in 2022?

Pro-Dex's stock was trading at $23.21 at the start of the year. Since then, PDEX shares have decreased by 24.6% and is now trading at $17.51.
View the best growth stocks for 2022 here
.

When is Pro-Dex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our PDEX earnings forecast
.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) issued its quarterly earnings results on Monday, November, 15th. The medical instruments supplier reported $0.28 earnings per share for the quarter, hitting the consensus estimate of $0.28. The medical instruments supplier had revenue of $9.99 million for the quarter. Pro-Dex had a trailing twelve-month return on equity of 16.75% and a net margin of 8.97%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Bank of America (BAC), Marvell Technology (MRVL) and UnitedHealth Group (UNH).

What is Pro-Dex's stock symbol?

Pro-Dex trades on the NASDAQ under the ticker symbol "PDEX."

Who are Pro-Dex's major shareholders?

Pro-Dex's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (1.62%), LSV Asset Management (0.91%) and Tower Research Capital LLC TRC (0.08%). Insiders that own company stock include Alisha Charlton, Katrina Marie Kramer Philp, Kirk Richard Lee Van Jr, Nicholas John Swenson, Raymond E Cabillot and William James Farrell III.
View institutional ownership trends
.

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pro-Dex's stock price today?

One share of PDEX stock can currently be purchased for approximately $17.51.

How much money does Pro-Dex make?

Pro-Dex (NASDAQ:PDEX) has a market capitalization of $62.69 million and generates $42.04 million in revenue each year. The medical instruments supplier earns $3.86 million in net income (profit) each year or $1.04 on an earnings per share basis.

How many employees does Pro-Dex have?

The company employs 117 workers across the globe.

How can I contact Pro-Dex?

Pro-Dex's mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The official website for the company is www.pro-dex.com. The medical instruments supplier can be reached via phone at (949) 769-3200, via email at investor.relations@pro-dex.com, or via fax at 949-769-3281.

This page (NASDAQ:PDEX) was last updated on 12/8/2022 by MarketBeat.com Staff